Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mihai Craiu has a total of 390 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Telemedicine in Retinopathy of Prematurity: A Review of Current Evidence and Clinical Outcomes

    by Ilinca-Medeea Iftime, Andreea-Ramona Treteanu, Andreea PușCașU, Mihai Craiu, Octaviana Cristea, Alina Angelica Ciolpan

    Background/Objectives: Retinopathy of prematurity (ROP) is a leading cause of preventable childhood visual impairment, particularly in settings where access to specialized ophthalmologic care is limited. Telemedicine offers an alternative approach to ROP screening and monitoring through remote retinal imaging and expert interpretation. This narrative review aimed to evaluate the diagnostic performance, clinical benefits, implementation challenges, and future perspectives of telemedicine in ROP screening and management. Methods: A narrative literature review was conducted with consideration of the Scale for the Assessment of Narrative Review Articles (SANRA) criteria. PubMed, Scopus, and Google Scholar were searched in August and August 2026 for relevant publications from January 2000 to the search date. Two authors independently screened titles and abstracts, followed by full-text assessment according to predefined eligibility criteria. A total of 143 scientific articles and other high-quality sources were included in the final narrative synthesis. Evidence was evaluated qualitatively, without a formal risk-of-bias assessment. Findings: The reviewed literature indicates that telemedicine can expand access to ROP screening, facilitate remote specialist consultation, support longitudinal disease monitoring, and improve the triage of infants requiring urgent assessment. In selected settings, remote retinal image interpretation has demonstrated diagnostic performance comparable to conventional examinations for clinically significant and vision-threatening ROP. Artificial intelligence-based assessment and smartphone-based retinal imaging represent promising approaches to improving screening accessibility and workflow efficiency, particularly in resource-limited settings. However, implementation remains constrained by equipment costs, infrastructure limitations, image quality, workforce training requirements, and ethical and legal considerations. Conclusions: Telemedicine represents a promising complementary strategy for ROP screening and management, with the potential to improve access to timely specialist assessment and help prevent ROP-related visual impairment. Its successful integration into clinical practice requires sustainable infrastructure, standardized protocols, trained personnel, and reliable referral pathways that ensure timely in-person examination and treatment when indicated. Further research is needed to establish the effectiveness, cost-efficiency, and long-term sustainability of different telemedicine-based approaches across diverse healthcare settings.

  • Open Access

    Patient-Reported Health-Related Quality of Life in Romanian Patients with Cystic Fibrosis in the Era of Highly Effective CFTR Modulator Therapy: A National Cross-Sectional Mixed-Methods Survey

    by Cristian Phillip Marinău, Cristian Sava, Alin Iuhas, Ioana Mihaiela Ciucă, Liviu Laurențiu Pop, Mihai Craiu, Zsolt Futaki, Ariana Szilagyi, Alexandru Jurca, Claudia Maria Jurca

    Background/Objectives: Highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy has changed cystic fibrosis (CF) care, but Romanian patient-reported health-related quality of life (HRQoL) data remain limited. This national cross-sectional mixed-methods survey aimed to describe patient- and parent-reported HRQoL in Romanian people with CF (pwCF) aged ≥6 years using age-appropriate Cystic Fibrosis Questionnaire-Revised (CFQ-R) versions, with the respiratory domain as the primary outcome. Methods: The online survey was conducted between February and April 2026. Respondents provided demographic and clinical data, including genotype/F508del status, CFTR modulator status, percent predicted forced expiratory volume in 1 s (ppFEV1) category, weight, height, and IV antibiotic-treated pulmonary exacerbations in the previous year. CFQ-R scores were summarized descriptively, and exploratory unadjusted associations were assessed using Mann–Whitney U tests and Spearman correlations. Open-ended responses were analyzed descriptively. Results: Of 67 responses, 61 were included: 43 participants aged 6–13 years and 18 aged ≥14 years. Most respondents were currently receiving CFTR modulators (52/61, 85.2%), predominantly elexacaftor/tezacaftor/ivacaftor. Mean CFQ-R Respiratory scores were 74.5 ± 23.1 in parent-proxy questionnaires for children aged 6–13 years, 83.3 ± 11.8 in self-reported questionnaires for children aged 12–13 years, and 69.8 ± 27.4 among respondents aged ≥14 years. Respiratory scores were higher among currently treated respondents and those with at least one F508del variant, and lower among those reporting IV antibiotic-treated exacerbations. Treatment burden remained among the lower-scoring domains. Qualitative responses described perceived respiratory, nutritional, and functional improvements, alongside residual treatment burden, psychosocial challenges, and access-related expectations. Conclusions: This national Romanian mixed-methods survey provides descriptive, exploratory CFQ-R-based HRQoL data in the CFTR modulator era. The findings suggest more favorable respiratory HRQoL among currently treated respondents, while supporting continued multidimensional patient-reported outcome monitoring in Romanian CF care.

  • Open Access

    Tidal-Breathing Analysis: A Potential Non-Invasive, Bedside Method for Objective Assessment of Respiratory Mechanics and Bronchodilator Responsiveness in Acute Bronchiolitis—Case Report and Review of the Literature

    by Mihai Craiu, Radu Marian Gheorghiu, Alexandra Bratu, Iustina Violeta Stan

    Background: Acute bronchiolitis is among the most common causes of lower-respiratory-tract infection in infancy and remains a clinically heterogeneous syndrome. Current international guidelines recommend supportive management and generally discourage routine bronchodilator administration; however, a subset of patients may be physiologically responsive. Tidal-breathing analysis (TBA) is a non-invasive, bedside method for objectively assessing respiratory mechanics and may objectively quantify physiological changes following bronchodilator administration in older children. Case Presentation: We report the case of a 23-month-old boy presenting with a severe RSV bronchiolitis-like wheezing illness complicated by acute respiratory failure. Bronchodilator responsiveness was evaluated using predefined TBA parameters before and after administration of an inhaled bronchodilator. Following treatment, the patient’s time to peak tidal expiratory flow (tPTEF) increased from 0.17 to 0.33 s (+94%), while his tPTEF/TE ratio increased from 0.12 to 0.27 (+125%). Expiratory time (TE) and total respiratory cycle duration (Ttot) decreased by 12.6% and 5.1%, respectively, whereas tidal volume (VT) and minute ventilation (MV) increased by 12.1% and 18.3%. Peak expiratory flow remained unchanged (0.14 L/s before and after bronchodilator administration). Discussion: To the best of our knowledge, this is among the first reports of using bedside TBA to characterize acute bronchodilator responsiveness in a severe bronchiolitis-like illness. The improvement in expiratory timing indices, along with the shorter expiratory time without changes in peak expiratory flow, is consistent with improved expiratory flow dynamics following bronchodilator administration. These findings could support the hypothesis that a bronchodilator-responsive physiological phenotype may exist. Previous studies have demonstrated an association between severe bronchiolitis during infancy and subsequent recurrent wheezing or asthma; however, whether acute bronchodilator responsiveness, measured objectively via TBA, is an indication of this phenotype represents a testable hypothesis for future longitudinal studies. Conclusions: This case illustrates the feasibility of bedside TBA for identifying physiological bronchodilator responsiveness in severe bronchiolitis-like illness. Prospective longitudinal studies should be conducted to determine whether TBA-defined responsiveness represents an early physiological marker requiring prospective validation and whether such physiological stratification may support individualized follow-up strategies.

  • Open Access

    Tidal Breathing Analysis Provides a Non-Invasive, Bedside Method for Objectively Assessing Respiratory Mechanics and Bronchodilator Responsiveness in Acute Bronchiolitis

    by Mihai Craiu, Radu Gheorghiu, Alexandra Bratu, Iustina Stan

    Background: Acute bronchiolitis is among the most common causes of lower respiratory tract infection in infancy and remains a clinically heterogeneous syndrome. Current international guidelines recommend supportive management and generally discourage routine bronchodilator administration; however, physiological responsiveness may exist in a subset of patients. Tidal breathing analysis (TBA) provides a non-invasive, bedside method for objectively assessing respiratory mechanics and may objectively quantify physiological changes following bronchodilator administration. Case Presentation: We report a 23-month-old boy presenting with severe RSV bronchiolitis-like wheezing illness complicated by acute respiratory failure. Bronchodilator responsiveness was evaluated using predefined TBA parameters before and after inhaled bronchodilator administration. Following treatment, time to peak tidal expiratory flow (tPTEF) increased from 0.17 to 0.33 s (+94%), while the tPTEF/TE ratio increased from 0.12 to 0.27 (+125%). Expiratory time (TE) and total respiratory cycle duration (Ttot) decreased by 12.6% and 5.1%, respectively, whereas tidal volume (VT) and minute ventilation (MV) increased by 12.1% and 18.3%. Peak expiratory flow remained unchanged (0.14 L/s before and after bronchodilator administration). Discussion: To our knowledge, this is among the first reports using bedside TBA to characterize acute bronchodilator responsiveness in severe bronchiolitis-like illness. The improvement in expiratory timing indices, accompanied by shorter expiratory time without changes in peak expiratory flow, is consistent with improved expiratory flow dynamics following bronchodilator administration. These findings support the hypothesis that a bronchodilator-responsive physiological phenotype may exist. Previous studies have demonstrated an association between severe bronchiolitis during infancy and subsequent recurrent wheezing or asthma; however, whether acute bronchodilator responsiveness, measured objectively by TBA, represents a testable hypothesis for future longitudinal studies. Conclusions: This case illustrates the feasibility of bedside TBA for identifying physiological bronchodilator responsiveness in severe bronchiolitis-like illness. Prospective longitudinal studies are warranted to determine whether TBA-defined responsiveness represents an early physiological marker requiring prospective validation and whether such physiological stratification may support individualized follow-up strategies.

  • Top Cited Papers
    Open Access

    Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis

    by Aida Perramon-Malavez, Antonio Chiaretti, Ermengol Coma, Mihai Craiu, Steve Foster, Paul Leonard, Robin Marlow, Valtýr Thors, Montserrat Martínez-Marcos, Jacobo Mendioroz, et al.


  • Open Access

    Pediatric Inhaled Medication: A Cross-Sectional Analysis on Usage Trends and Parental Perceptions in Romania

    by Alina Angelica Ciolpan, Mihai Craiu, Andreea Pușcașu, Mihai Alexandru Borcan, Valentina Daniela Comănici

    Background: Inhaled medications are central in managing pediatric respiratory diseases, yet device complexity and nebulizer use often challenge caregivers and affect adherence. This study assessed current usage patterns and parental perceptions of inhaled therapies in Romania, aiming to identify modifiable factors for targeted education. Methods: A cross-sectional observational survey was distributed via SVC® (Spitalul Virtual pentru Copii—Virtual Children’s Hospital), a widely accessed social media platform for Romanian parents. Data included demographics, inhaled medication use, prescribing sources, adherence, and treatment perceptions. Results: A total of 1825 parents participated, mostly urban residents (87.6%). Chronic respiratory disease, mainly asthma, was reported in 7.3% of children. Inhaled therapy was used in 71.9% of cases, predominantly saline solutions, bronchodilators, and corticosteroids, marking a decline compared with the past decade. Nebulizers (74.1%) were the main devices used. Prescriptions were largely pediatrician-based, though self-medication occurred, particularly with saline solutions, often influenced by non-medical sources (p = 0.003). Parents of children with chronic disease were less likely to self-medicate (p = 0.042), especially with β2-agonists and corticosteroids (p < 0.001). Additionally, 31.3% reported use of complementary remedies, including homeopathy. Overall, 73.5% perceived inhaled therapy as effective, with adverse events reported by only 8.3%. Conclusions: Inhaled therapy remains prevalent in Romanian children, though self-medication and alternative treatments persist, shaped by cultural factors and limited medical education. Parents of children with chronic disease show better adherence and reliance on prescribed therapy. Enhancing parental education via accessible digital platforms may reduce inappropriate practices and improve outcomes in low-resource settings.


  • Open Access

    Pediatric Inhaled Medication: A Cross-Sectional Analysis on Usage Trends and Parental Perceptions in Romania

    by Alina Angelica Ciolpan, Mihai Craiu, Andreea Pușcașu, Mihai Alexandru Borcan, Valentina Daniela Comănici

    Background: Inhaled medications are central in managing pediatric respiratory diseases, yet device complexity and nebulizer use often challenge caregivers and affect adherence. This study assessed current usage patterns and parental perceptions of inhaled therapies in Romania, aiming to identify modifiable factors for targeted education. Methods: A cross-sectional observational survey was distributed via SVC® (Spitalul Virtual pentru Copii – Virtual Children’s Hospital), a widely accessed social media plat-form for Romanian parents. Data included demographics, inhaled medication use, pre-scribing sources, adherence, and treatment perceptions. Results: A total of 1,825 parents participated, mostly urban residents (87.6%). Chronic respiratory disease, mainly asthma, was reported in 7.3% of children. Inhaled therapy was used in 71.9% of cases, predominantly saline solutions, bronchodilators, and corti-costeroids, marking a decline compared with the past decade. Nebulizers (74.1%) were the main devices used. Prescriptions were largely pediatrician-based, though self-medication occurred, particularly with saline solutions, often influenced by non-medical sources (p=0.003). Parents of children with chronic disease were less likely to self-medicate (p=0.042), especially with β-agonists and corticosteroids (p< 0.001). Additionally, 31.3% reported use of complementary remedies, including homeopathy. Overall, 73.5% perceived inhaled therapy as effective, with adverse events reported by only 8.3%. Conclusions: Inhaled therapy remains prevalent in Romanian children, though self-medication and alternative treatments persist, shaped by cultural factors and limited medical education. Parents of children with chronic disease show better adherence and reliance on prescribed therapy. Enhancing parental education via accessible digital platforms may reduce inappropriate practices and improve outcomes in low-resource settings.

  • Open Access

    Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021–May 2023

    by Camelia Savulescu, Albert Prats-Uribe, Kim Brolin, Zvjezdana Lovrić Makarić, Anneli Uusküla, Georgios Panagiotakopoulos, Colm Bergin, Catherine Fleming, Antonella Agodi, Paolo Bonfanti, et al.

    Background: European countries have included healthcare workers (HCWs) among priority groups for COVID-19 vaccination. We established a multi-country hospital network to measure the SARS-CoV-2 incidence and effectiveness of COVID-19 vaccines among HCWs against laboratory-confirmed SARS-CoV-2 infection. Methods: HCWs from 19 hospitals in 10 countries participated in a dynamic prospective cohort study, providing samples for SARS-CoV-2 testing at enrolment and during weekly/fortnightly follow-up. We measured the incidence during pre-Delta (2 May–6 September 2021), Delta (7 September–14 December 2021), and Omicron (15 December 2021–2 May 2023) waves. Using Cox regression, we measured the relative vaccine effectiveness (rVE) of the first COVID-19 booster dose versus primary course alone during Delta and Omicron waves. Results: We included a total of 3015 HCWs. Participants were mostly female (2306; 79%), with a clinical role (2047; 68%), and had a median age of 44 years. The overall incidence of SARS-CoV-2 infection was 3.01/10,000 person-days during pre-Delta, 4.21/10,000 during Delta, and 23.20/10,000 during Omicron waves. rVE was 59% (95% CI: −25; 86) during Delta and 22% (1; 39) during Omicron waves. rVE was 51% (30; 65) 7–90 days after the first booster dose during the Omicron wave. Conclusions: The incidence of SARS-CoV-2 infection among HCWs was higher during the Omicron circulation period. The first COVID-19 vaccine booster provided additional protection against SARS-CoV-2 infection compared to primary course vaccination when recently vaccinated <90 days. This multi-country HCW cohort study addressing infection as the main outcome is crucial for informing public health interventions for HCWs.


  • Open Access

    Exploring the Clinical Characteristics and Outcomes of Rhinovirus Infection in Hospitalized Children Compared with Other Respiratory Viruses

    by Sigrid Covaci, Claudiu Filimon, Mihai Craiu

    Background: Acute viral respiratory tract infections constitute a significant challenge in pediatric healthcare globally, with rhinovirus representing one of the primary etiological agents. In this context, we conducted a study with the objective of identifying the clinical characteristics and outcomes of rhinovirus infection in comparison with other respiratory viruses in children hospitalized in one of the largest pediatric hospitals in the capital of Romania. Methods: We conducted a retrospective study among children hospitalized for influenza-like illness symptoms and who were tested by multiplex RT-PCR with a nasopharyngeal swab between May 2020 and December 2021. Results: A total of 496 children were eligible for inclusion in the study, and the positivity rate for at least one virus was 58.5%. The rhinovirus was identified in 138 patients (median age 12.5 months), representing 27.8% of all children tested and 49.3% of all positive samples. Although the clinical features of children with rhinovirus were dominated by cough (63.7%) and dyspnea (51.6%), no symptoms were identified that were strongly associated with rhinovirus infection in comparison to other respiratory viruses. The probability of receiving an antibiotic prescription was 1.92 times lower (p = 0.011) in children who tested positive for rhinovirus compared to children with negative RT-PCR results. The incidence of acute bronchiolitis or acute bronchitis, acute respiratory failure, and acute otitis media was higher among rhinovirus-positive children than among those who tested negative via RT-PCR. However, the incidence of these conditions was similar among children who tested positive for other respiratory viruses. Conclusions: Rhinovirus was the most prevalent virus identified in children hospitalized with influenza-like illness symptoms. The utilization of multiplex RT-PCR molecular tests is instrumental in elucidating etiology with precision and implementation of these advanced diagnostic methods, which can bring significant benefits in practice. A positive result for rhinovirus helps to reduce the unnecessary administration of antibiotics and optimizes patient management, thus decreasing the risk of severe complications such as acute respiratory failure and acute otitis media.


  • Open Access

    Integrating Artificial Intelligence in Pediatric Healthcare: Parental Perceptions and Ethical Implications

    by Elena Camelia Berghea, Marcela Daniela Ionescu, Radu Marian Gheorghiu, Iulia Florentina Tincu, Claudia Oana Cobilinschi, Mihai Craiu, Mihaela Bălgrădean, Florian Berghea

    Background: Our study aimed to explore the way artificial intelligence (AI) utilization is perceived in pediatric medicine, examining its acceptance among patients (in this case represented by their adult parents), and identify the challenges it presents in order to understand the factors influencing its adoption in clinical settings. Methods: A structured questionnaire was applied to caregivers (parents or grandparents) of children who presented in tertiary pediatric clinics. Results: The most significant differentiations were identified in relation to the level of education (e.g., aversion to AI involvement was 22.2% among those with postgraduate degrees, 43.9% among those with university degrees, and 54.5% among those who only completed high school). The greatest fear among respondents regarding the medical use of AI was related to the possibility of errors occurring (70.1%). Conclusions: The general attitude toward the use of AI can be considered positive, provided that it remains human-supervised, and that the technology used is explained in detail by the physician. However, there were large differences among groups (mainly defined by education level) in the way AI is perceived and accepted.